Buscar
Mostrando ítems 1-10 de 19
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
(Sociedade Brasileira de Cardiologia - SBC, 2012-04-01)
BACKGROUND: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal ...
Effect of oral sirolimus therapy on inflammatory biomarkers following coronary stenting
(Associação Brasileira de Divulgação Científica, 2010-08-01)
We studied the effect of oral sirolimus, administered to prevent and treat in-stent restenosis (ISR), on the variation of serum levels of inflammatory markers following coronary stenting with bare metal stents. The mean ...
Impacto dos stents e do sirolimus por via oral na vasomotricidade coronariana dependente e independente do endotélio
(Universidade Federal de São Paulo (UNIFESP), 2012-05-30)
Rationale: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with Sirolimus-eluting stents as compared to bare metal ...
CLOVES syndrome: Treatment with oral Rapamycin. Report of two cases
(2019)
Introduction: CLOVES syndrome is characterized by lipomatous overgrowth associated with vascular malforma tions, representing a diagnostic and a therapeutic challenge. Rapamycin, an mTOR inhibitor, has proved to be a good ...
Rescate con Sirolimus por rechazo agudo recurrente y diabetes mellitus en trasplante hepático: Caso clínico pediátrico
(Sociedad Médica de Santiago, 2005)
Avaliação da resposta inflamatória sistêmica após o implante de stents coronários em pacientes em uso de rapamicina por via oral
(Universidade Federal de São Paulo (UNIFESP), 2010-04-28)
Recent findings in basic and experimental science have supported the notion that atherosclerosis is characterized by a chronic inflammatory vascular response and it is not only a bland lipid storage disease. It is also ...
Efficacy and safety of oral sirolimus to inhibit in-stent intimal hyperplasia
(Wiley-Blackwell, 2005-04-01)
Sirolimus systemic administration has shown marked inhibition of neointimal hyperplasia (NIH) after balloon angioplasty in porcine models. in this pilot study, we tested the hypothesis that oral sirolimus is safe and ...
Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice
(2009-12)
The objective of the present study was to assess the effects of the immunosuppressant rapamycin (Rapamune®, Sirolimus) on both resistance vessel responsiveness and atherosclerosis in apolipoprotein E-deficient 8-week-old ...
Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine
(Associação Brasileira de Divulgação Científica, 2004-09-01)
The use of sirolimus (SRL) in combination with full doses of cyclosporin A (CsA) results in reduced one-year kidney allograft function, which is associated with shorter long-term allograft survival. We determined the effect ...